Wholesale of other food
NORWEGIAN PHARMA AS
Revenue 2025
NOK 8.5m
Operating profit
NOK 1.3m
Equity
NOK 2.9m
Incorporated
2009
Share capital
NOK 100,000
Key figures · 2025
Current ratio
3.68
Equity ratio
72.5%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 15.7% | |
| Net margin (%%) | 12.4% | |
| Return on assets (%%) | 34.0% | |
| Likviditet | ||
| Current ratio | 3.68 | |
| Working capital | 2.9m | |
| Soliditet | ||
| Equity ratio (%%) | 72.5% | |
| Debt-to-equity ratio | 0.38 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.